Cognitive biomarker assays inform safety and efficacy decisions by measuring network potentiation and synaptic plasticity Advances the emerging field of organoid intelligence for drug development applications NEW ORLEANS -- 28bio today launched CNS-3D Plasticity Organoids, enabling human functional endpoints of learning and memory before drug candidates enter clinical testing. Attrition in neurodegeneration remains among the highest [...]

New handheld spectrophotometer will be showcased with digital color workflow solutions at LOUPE Americas and PRINTING United Expo. GRAND RAPIDS, Mich. -- X-Rite Pantone, the global authority in color standards and color science, announces eXact™ 2 Basic, the newest addition to the eXact 2 family of portable spectrophotometers. Available now, the new device will be showcased [...]

Milestone release introduces L7|SYNAPSE™ AI framework, up to 100x performance boost, and advanced NORs & PARs compliance modeling to power mission-critical operations. AUSTIN, Texas — L7 Informatics, Inc., a provider of foundational data orchestration and digital transformation infrastructure for precision sciences, today announced the general availability of L7|ESP 2026.1. Building on a unified composable data [...]

Introducing a new AI approach for accelerated biomarker discovery, demonstrated through Alzheimer’s disease biomarker modeling validated in an independent cohort Basel, Switzerland -- Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new AI agent in Genedata Profiler®, its enterprise platform for integrating and analyzing data across [...]

ZEISS Spectroscopy has launched ZEISS SPARC (Spectroscopic Process Analysis & RDF/SRF Control), an innovative inline solution for quality control of alternative fuels in the cement industry. The system will be presented at the Global CemFuels Conference 2026 in Geneva on September 23 and 24, 2026. Jena, Germany | ZEISS Group ZEISS SPARC continuously determines the [...]

Newly-created Chief Technology Officer role marks a new chapter for bit.bio as the company expands its leadership team and technology portfolio The ioScreen platform enables pharmaceutical, biotechnology and in silico companies to access industrial-scale CRISPR screening in human stem cell-derived models without building specialist in-house capabilities Service gives researchers a more physiologically relevant way to [...]

CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximising CHO cell productivity CHO.SET® promoters enable higher protein titres, reduced costs and shorter development timelines Sheffield, UK: SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the introduction of [...]

Xylem (NYSE: XYL), a global water technology leader, today announced that D. Christian Koch has been appointed to the Company’s Board of Directors. Mr. Koch brings more than 30 years of global leadership experience spanning operations, manufacturing, strategy and business transformation. He currently serves as Board Chair, President and Chief Executive Officer of Carlisle Companies [...]

Grant funding delivered in partnership with the NC3Rs, in support of UK Government roadmap to reduce animal testing by 2030 Project to develop standardized workflow to more accurately predict drug behaviors, reduce animal testing and streamline development of safer, more effective medicine Delivered in partnership with the National Centre for the Replacement, Refinement and Reduction [...]

WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility [...]